| #18 |
Lisa Marie Pratt |
British Biotech Pharmaceuticals |
1 |
| #18 |
Henry Doucet |
Isis Innovation Limited |
1 |
| #18 |
Geoffrey Sallows |
Brightwell Dispensers Limited |
1 |
| #18 |
Rory Warner |
GE |
1 |
| #18 |
Gareth Wakefield |
Isis Innovation Limited |
1 |
| #18 |
Benjamin Phalen Oates |
Unilever Home & Personal Care Usa, Division Of Conopco |
1 |
| #18 |
Timor Kadir |
Mirada Medical Limited |
1 |
| #18 |
Garreth Wakefield |
Isis Innovation Limited |
1 |
| #18 |
Anna Mary Myat |
Imperial Cancer Research Technology |
1 |
| #18 |
Merlyn P. Young |
Philips |
1 |
| #18 |
Robert Martin Finnegan |
— |
1 |
| #18 |
Aijaz Akhtar |
— |
1 |
| #18 |
Duncan Carmichael |
Isis Innovation Limited |
1 |
| #18 |
John Martin Clements |
British Biotech Pharmaceuticals |
1 |
| #18 |
Andrew Paul Ayscough |
British Biotech Pharmaceuticals |
1 |
| #18 |
Helen Katherine Smith |
Aventis Pharmaceuticals |
1 |
| #18 |
Cheng Tsien Chou |
Oxford Instruments Analytical Limited |
1 |
| #18 |
Fiona Winterbottom |
Accentus Plc |
1 |
| #18 |
Paul Harffey |
Infineum International Limited |
1 |
| #18 |
David Massingham |
Oxford Instruments Superconductivity |
1 |
| #18 |
Peter Mile Cetnik |
Oxford Instruments Superconductivity |
1 |
| #18 |
Erik Emil Anggard |
— |
1 |
| #18 |
Hugh A. O. Hill |
Medisense |
1 |
| #18 |
Mark Moloney |
Isis Innovation Limited |
1 |
| #18 |
Ian Day |
Bookham Technology, Plc |
1 |
| #18 |
Nicholas J. Wald |
3I Research Exploitation Limited |
1 |
| #18 |
Rinaldo Caprotti |
ExxonMobil |
1 |
| #18 |
Hans-Jörg Himmel |
Isis Innovation Limited |
1 |
| #18 |
Rimvydas Juskaitis |
Isis Innovation Limited |
1 |
| #18 |
Christopher William Pugh |
Isis Innovation Limited |
1 |
| #18 |
David Davies |
Battelle Memorial Institute |
1 |